1. Home
  2. KMT vs STOK Comparison

KMT vs STOK Comparison

Compare KMT & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kennametal Inc.

KMT

Kennametal Inc.

HOLD

Current Price

$33.67

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$30.32

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KMT
STOK
Founded
1938
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
KMT
STOK
Price
$33.67
$30.32
Analyst Decision
Hold
Strong Buy
Analyst Count
6
10
Target Price
$29.67
$34.50
AVG Volume (30 Days)
776.6K
813.5K
Earning Date
02-04-2026
11-04-2025
Dividend Yield
2.40%
N/A
EPS Growth
N/A
N/A
EPS
1.22
0.68
Revenue
$1,982,871,000.00
$205,632,000.00
Revenue This Year
$9.06
$430.24
Revenue Next Year
$4.15
N/A
P/E Ratio
$27.27
$44.66
Revenue Growth
N/A
1128.17
52 Week Low
$17.30
$5.35
52 Week High
$34.14
$38.69

Technical Indicators

Market Signals
Indicator
KMT
STOK
Relative Strength Index (RSI) 82.67 45.38
Support Level $28.93 $25.21
Resistance Level $34.14 $37.34
Average True Range (ATR) 0.76 1.89
MACD 0.36 -0.42
Stochastic Oscillator 92.14 43.28

Price Performance

Historical Comparison
KMT
STOK

About KMT Kennametal Inc.

Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: